3rd Annual “Induced Pluripotent Stem Cells
Production and Utility in Regenerative Medicine"
4th October 2012

Human induced pluripotent stem cells (hiPSCs) generated by reprogramming somatic cells represent an unique opportunity for regenerative medicine. Indeed, hIPSCs can proliferate indefinitely in vitro while maintaining the capacity to differentiate into broad number of cell type. Therefore, hIPSCs could be used to produce an infinite quantity of cell type with a clinical interest. In addition, hIPSCs could enable the production of patient specific cell types which are fully immuno-compatible with the original donor thereby avoiding the need for immune suppressive treatment during cell based therapy. However, recent reports have suggested that epigenetic and genetic anomalies associated with direct reprogramming technology could limit the interest of hIPSCs for in vivo use.

This 3rd Annual event will review the drawback and advantages of hIPSCs for diverse type of clinical applications.

This event  has CPD accreditation and will have a  discussion panel session.  

On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event

Meeting Chair:  Lyn Healy, NIBSCC, South Mimms, UK

Expected Number of Attendees

MA

View Conference Website: 3rd Annual “Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine"

Price of Attendance

n/a

Brochure

View Event Brochure

Location

The Penridge Suite
470 Bowes Road
London
United Kingdom
N11 1NL